Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 27;17(1):226.
doi: 10.1186/s12944-018-0870-x.

Stroke and dyslipidemia: clinical risk factors in the telestroke versus non-telestroke

Jordan Gainey  1 , Brice Blum  1 , Bekah Bowie  1 , Keiko Cooley  1 , Lee Madeline  2 , Ervin Lowther Ervin  2 , Thomas I Nathaniel  3
Affiliations

Stroke and dyslipidemia: clinical risk factors in the telestroke versus non-telestroke

Jordan Gainey et al. Lipids Health Dis. .

Abstract

Background: Clinical risk factors related to not administering thrombolysis to acute ischemic stroke patients with incidence dyslipidemia is not clear. This issue was investigated in telestroke and non-telestroke settings.

Methods: We analyzed retrospective data collected from a stroke registry to compare exclusion risk factors in the telestroke and non-telestroke. We performed multivariate analysis was performed to identify risk factors that may result in exclusion from rtPA. Variance inflation factors were used to examine multicollinearity and significant interactions between independent variables in the model, while Hosmer-Lemeshow test, Cox & Snell were used to determine the fitness of the regression models.

Results: A greater number of patients with acute ischemic stroke with incidence dyslipidemia were treated in the non-telestroke (285) when compared with the telestroke network (187). Although non-telestroke admitted more patients than the telestroke, the telestroke treated more patients with rtPA (89.30%) and excluded less (10.70%), while the non-telestroke excluded from rtPA (61.40%). In the non-telestroke, age (adjusted OR, 0.965; 95% CI, 0.942-0.99), blood glucose level (adjusted OR, 0.995; 95% CI, 0.99-0.999), international normalized ratio (adjusted OR, 0.154; 95% CI, 0.031-0.78),congestive heart failure(CHF) (adjusted OR, 0.318; 95% CI, 0.109-0.928), previous stroke (adjusted OR, 0.405; 95% CI, 0.2-0.821) and renal insufficiency (adjusted OR, 0.179; 95% CI, 0.035-0.908) were all directly linked to exclusion from rtPA. In the telestroke, only body mass index (adjusted OR, 0.911; 95% CI, 0.832-0.997) significantly excluded acute ischemic stroke patients with incidence dyslipidemia from thrombolysis therapy.

Conclusion: Despite having more patients with acute ischemic stroke that present incidence dyslipidemia, the non-telestroke patients had more clinical risk factors that excluded more patients from rtPA when compared with telestroke. Future studies should focus on how identified clinical risk factors can be managed to improve the use of rtPA in the non-telestroke setting. Moreover, the optimization of the risk-benefit ratio of rtPA by the telestroke technology can be advanced to the non-telestroke setting to improve the use of thrombolysis therapy.

Keywords: Acute ischemic stroke patients; Dyslipidemia; Non-telestroke; Telestroke; rtPA.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This study is a retrospective data analysis, and was approved by Institutional Review Board of Greenville Health System and the institutional Committee for Ethics.

Consent for publication

All co-authors agreed to the submission of the manuscript.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z. Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with Oral anticoagulation therapy: insights from the ARISTOTLE (Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation) trial. J Am Heart Assoc. 2018;7.3:1–11. - PMC - PubMed
    1. Koton S, Schneider ALC, Rosamond WD, Shahar E, Sang YY, Gottesman RF, et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA. 2014;312(3):259–268. doi: 10.1001/jama.2014.7692. - DOI - PubMed
    1. Jain M, Jain A, Yerragondu N, Brown RD, Rabinstein A, Jahromi B. The triglyceride paradox in stroke survivors: a prospective study. Neurosci J. 2013;12:34–41. - PMC - PubMed
    1. Lu D, Li P, Zhou YY, Xu XI XL, Liu LP, Tian Z. Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke. BMC Neurol. 2016;16:154. - PMC - PubMed
    1. Dziedzic T, Pera J, Slowik A, Gryz-Kurek EA, Szczudlik A. Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr. 2007;61(11):1318–1322. doi: 10.1038/sj.ejcn.1602643. - DOI - PubMed

MeSH terms

LinkOut - more resources